(Q34560849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Richard A Edrich

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Junzhi Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jerard Seghatchian

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

28 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

5-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

Current and emerging infectious risks of blood transfusions

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Advances in photochemical approaches for blood sterilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Preliminary studies of photoinactivation of human immunodeficiency virus in blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photodynamic therapy of viral contaminants with potential for blood banking applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

7 January 2021

Riboflavin Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photoconversion of riboflavin to lumichrome in plant tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photochemical degradation of flavines. VI. New photoproduct and its use in studying the photolytic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photo-induced riboflavin binding to the tryptophan residues of bovine and human serum albumins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Further observations on the photooxidation of DNA in the presence of riboflavin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photodegradation of DNA with fluorescent light in the presence of riboflavin, and photoprotection by flavin triplet-state quenchers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical O2-. mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photosensitized formation of 8-hydroxydeoxyguanosine in cellular DNA by riboflavin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Potential for genetic damage from multivitamin solutions exposed to phototherapy illumination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Formation of 8-hydroxyguanine and 2,6-diamino-4-hydroxy-5-formamidopyrimidine in DNA by riboflavin mediated photosensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Short communication. Photochemical reactions of riboflavin: covalent binding to DNA and to poly (dA) . poly (dT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

West Nile virus blood transfusion-related infection despite nucleic acid testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Single-donor platelets reduce the risk of septic platelet transfusion reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

International forum: granulocyte transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

WITHDRAWN: The platelet storage lesion: A comparative analysis of six leukoreduction processes in terms of biocompatability, microvesiculation, retention of prions, and generation/removal of biological response modifiers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Effect of processing and storage on platelet activation, cellular injury and microvesiculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.01.007

10.1016/J.TRANSCI.2006.01.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16935562%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference